D.E. Shaw & Co
VANI icon

D.E. Shaw & Co’s Vivani Medical VANI Stock Holding History

D.E. Shaw & Co’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-576
Closed -$17K – 3621
2017
Q2 		$17K Buy
576
+12
+2% +$339 ﹤0.01% 3327
2017
Q1 		$16K Buy
+564
New +$21.6K ﹤0.01% 3239
2016
Q2 		– Sell
-1,480
Closed -$172K – 3546
2016
Q1 		$172K Buy
1,480
+514
+53% +$59.1K ﹤0.01% 3219
2015
Q4 		$137K Buy
+966
New +$141K ﹤0.01% 3639

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CD
Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return

D.E. Shaw & Co's VANI Position: Q3 2017 in Review

D.E. Shaw & Co sold out of Vivani Medical (VANI) in Q3 2017, closing a stake of 576 shares — an estimated $17K sold.

D.E. Shaw & Co first reported a position in VANI in Q4 2015 and held it in 4 quarters. The position peaked at $172K in Q1 2016. 43 funds tracked by Wall St. Rank hold VANI as of Q3 2017.

  • D.E. Shaw & Co reported no remaining Vivani Medical position as of Q3 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 576 Vivani Medical shares in Q3 2017, an estimated $17K.
  • D.E. Shaw & Co first reported a position in Vivani Medical in Q4 2015 and held it in 4 quarters.
  • D.E. Shaw & Co's Vivani Medical position peaked at $172K in Q1 2016.
  • 43 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2017.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.